CLNINDIA · NSE: CLNINDIA · BSE: 506390
Q4 FY21 results · Jan–Mar 2021
CLNINDIA reported revenue from operations of ₹218.84 crore (up 29.1% from Q4 FY20) and net profit of ₹10.97 crore (down 28.6% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 218.84 | 169.48 | +29.1% | 202.10 | +8.3% |
| Other income | 4.61 | 8.81 | −47.7% | 3.03 | +52.1% |
| Total income | 223.45 | 178.29 | +25.3% | 205.13 | +8.9% |
| Profit before tax | 22.74 | 10.67 | +113.1% | 19.00 | +19.7% |
| Net profit for the period | 10.97 | 15.37 | −28.6% | 13.20 | −16.9% |
| EPS, basic (₹) | 4.75 | 6.62 | −28.2% | 5.72 | −17.0% |
| Net margin (%) | 5.0 | 9.1 | 6.5 |
Standalone
- Filed with BSE
- 19 May 2021, 19:58 IST
- Board meeting
- 19 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE